Rochester, Minnesota, United States
The Application Analyst-CDS plays a vital role in the analysis, development and support of Epic Clinical Decision Support and development of Best Practice Advisories. The application analyst works collaboratively with other clinical application analysts, leadership, clinical, informatics and administrative staff to build specifications, build, test, and support the changes to the Epic application. The IT application analyst maintains in-depth knowledge of existing systems and certification in the vended application. Able to design, develop, or modify applications, algorithms, or rules and are able to validate data integrity of changes introduced.
The INS in Rochester functions in a variety of roles including team leader, project manager, consultant and team member on project and committees for the organization as well as nursing. They stay informed on a wide variety of operational nursing initiatives and nursing practice drivers that greatly impact project need, timing, and priority level. At the interdisciplinary table, the INS offers a skill set that may overlap with others on the group; however, they are ultimately accountable to assure that an efficient nursing workflow is incorporated and that the best nursing practice is represented. This is done by engaging nursing colleagues for clearly defining the system requirements. Working with the practice, the INS is instrumental in helping the user to translate workflows which represent best practices into system requirements. The INS understands and assures that the system requirements include the capacity to measure the impact of practices. This informs the practice, leads to creation of knowledge, and potential practice improvements. The INS understands the appropriate documentation tools, the data needed, when it’s needed and all aspects of its use. They continually analyze use of the IT tools to identify whether there are other functions that may be leveraged to transform the practice.
Worked with chemically dependent adolescent patients. It was an inpatient 30 day treatment program.